Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Xiang, R.
  • Luo, Y. P.
  • Niethammer, A. G.
  • Reisfeld, Ralph

publication date

  • 2008

journal

  • Immunological Reviews  Journal

abstract

  • Four novel oral DNA vaccines provide protection against melanoma, colon, breast, and lung carcinoma in mouse models. Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME). These vaccines are all capable of inducing potent cell-mediated protective immunity against self-antigens, resulting in marked suppression of tumor growth and dissemination. Key mechanisms induced by these DNA vaccines include efficient suppression of angiogenesis in the tumor vasculature and marked activation of cytotoxic T cells, natural killer cells, and antigen-presenting dendritic cells. The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis. This, in turn, remodels the TME and decreases its immunosuppressive milieu and thereby potentiates the DNA vaccine's ability to effectively suppress tumor cell proliferation, vascularization, and metastasis. It is anticipated that such research efforts will lead to novel DNA-based vaccines that will be effective for the treatment of cancer.

subject areas

  • Administration, Oral
  • Animals
  • CD8-Positive T-Lymphocytes
  • Chemokine CCL21
  • Gene Transfer Techniques
  • Immunologic Memory
  • Immunotherapy
  • Inhibitor of Apoptosis Proteins
  • Interleukin-18
  • Killer Cells, Natural
  • Lymphocyte Activation
  • Mice
  • Microtubule-Associated Proteins
  • Neoplasm Invasiveness
  • Neoplasms, Experimental
  • Neovascularization, Pathologic
  • Proto-Oncogene Proteins c-fos
  • Repressor Proteins
  • Salmonella typhimurium
  • Self Tolerance
  • Vaccines, DNA
  • Vascular Endothelial Growth Factor Receptor-2
scroll to property group menus

Research

keywords

  • DNA vaccines
  • angiogenesis
  • cytotoxic T cells
  • tumor microenvironment
  • tumor suppression
  • tumor vasculature
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0105-2896

Digital Object Identifier (DOI)

  • 10.1111/j.1600-065X.2008.00613.x

PubMed ID

  • 18363997
scroll to property group menus

Additional Document Info

start page

  • 117

end page

  • 128

volume

  • 222

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support